Skip to main content

Tropsha Named Chair of the Division of Medicinal Chemistry and Natural Products

March 29, 2006

Alexander Tropsha, PhD, has been named chair of the Division of Medicinal Chemistry and Natural Products. He has served as interim chair of the division since last July. “I am delighted to announce Dr. Tropsha’s new position,” said Robert Blouin, dean of the School. “Dr. Tropsha has been a faculty member at the School for more than ten years, and he has done an excellent job of providing leadership for the division since last summer.” Tropsha is a professor of medicinal chemistry and director of the Laboratory for Molecular Modeling at the School of Pharmacy. He directs the UNC Graduate Program … Read more

Patterson Assists in the Creation of HFSA Guidelines

March 15, 2006

Herb Patterson, PharmD, participated in the Heart Failure Society of America committee that developed recently published HFSA guidelines. Patterson was one of only 25 individuals selected from across the country to participate in the group.

White-Harris Receives Inaugural Mentoring Award

March 13, 2006

Carla White-Harris, a clinical assistant professor at the UNC School of Pharmacy, received one of the University’s first Carolina Women’s Leadership Council Mentoring Awards, which was presented at the council’s recent annual meeting. The award recognizes outstanding faculty members who go the extra mile to guide, mentor, and lead students and junior faculty members as they make important career decisions, embark on innovative research challenges and enrich their lives through public service, teaching, and meaningful educational opportunities. Each recipient receives a $5,000 stipend. White-Harris, who is also director of the School’s Pharmaceutical Care Labs, received the award for the faculty-to-student category. One of … Read more

Brouwer to Participate in International Transporter Working Group

February 24, 2006

Kim Brouwer, PhD, has been selected to to participate in a working group of drug transporter biologists. The goal of the working group is to develop standards for transporter assays that can be used experimentally to study drug transporter interactions in the setting of the drug approval process. Drug interactions with transporters in cellular assays are increasingly being studied during pre-clinical drug development. These studies are used in predictive absorption, distribution, metabolism and excretion (ADME) studies to predict pharmacokinetic properties and to select which drug among a set of candidate drugs to advance to clinical trials. Further, the studies are used … Read more

UNC-Chapel Hill School of Pharmacy Names First Executive Associate Dean

February 10, 2006

Gary Pollack, Ph.D., has been appointed as the first executive associate dean for the University of North Carolina at Chapel Hill School of Pharmacy. “I am delighted that Dr. Pollack has agreed to accept this important position within the School of Pharmacy,” said Robert Blouin, dean of the School. “Dr. Pollack has been a distinguished scientist and educator at the School for over 20 years, and his exceptional leadership skills will contribute greatly to the future success of the School.” As executive associate dean, Pollack will oversee all aspects of the School’s operations and will represent the dean in various … Read more

Ives Elected Secretary of the Pharmacy Practice Section

February 10, 2006

Tim Ives has been elected secretary of the AACP Pharmacy Practice Section. The section fosters excellence in education, research, and practice through the development and implementation of policies and programs.

Pharmacy Researchers Find New Way to Produce Popular Anticoagulant

February 7, 2006

Scientists at the UNC School of Pharmacy and Rensselaer Polytechnic Institute have discovered an alternative way to produce heparin, a drug commonly used to stop or prevent blood from forming dangerous clots. Heparin is most often used during and after such procedures as kidney dialysis, heart-bypass surgery, stent implantation, indwelling catheters, and knee and hip replacement to prevent clots from forming and blocking or restricting the flow of blood. The annual worldwide sales of heparin are estimated at $3 billion. “Synthesizing heparin chemically is extremely difficult, but by doing so, we eliminate the risk of viruses and other forms of … Read more

Hickey Elected AAAS Fellow

February 6, 2006

Hickey Elected Fellow by American Association for the Advancement of Science By Jim Walsh UNC News Services Anthony Hickey, PhD, has been elected as a fellow of the American Association for the Advancement of Science for his efforts to advance science or its applications. He, along with the other 375 fellows for 2005, will be recognized for their contributions at a February 18 forum during the AAAS annual meeting. The AAAS, a nonprofit organization, seeks to advance science worldwide by serving as an educator, leader, spokesperson and professional association. The association publishes the journal Science, in addition to newsletters, books, … Read more

Hadzija Inducted into Frank Porter Graham Honor Society

February 6, 2006

Boka W. Hadzija, Ph.D., has been inducted into the Frank Porter Graham Honor Society in recognition of her extraordinary commitment to the education of graduate and professional students through mentoring, teaching, and support. The Society was created in 1990 in honor of former University of North Carolina system President Frank Porter Graham. Inductees are graduate and professional students from the University of North Carolina at Chapel Hill who have demonstrated service above and beyond requirements for their degrees or position. The society also recognizes faculty, staff, and friends of the University who have made significant contributions to the development of … Read more

Kashuba Awarded “Paper of the Year” by SIDP

December 14, 2005

A manuscript by associate professor Angela Kashuba has been selected by the Society of Infectious Diseases Pharmacists as “Paper of the Year.” The manuscript is entitled “Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results”. The Society of Infectious Diseases Pharmacists is an association of health professionals dedicated to promoting the appropriate use of antimicrobials. SIDP provides education, advocacy and leadership in all aspects of the treatment of infectious diseases.